Ozempic and other glucagon-like peptide-1 (GLP-1) agonists are a transformative new class of medicines for the treatment of diabetes and obesity, while also delivering other health benefits, such as ...

The remarkable efficacy of new diabetes and weight loss medicines like Ozempic and Mounjaro have been one of the biggest health stories of recent years. Despite rising rates of diabetes and obesity, ...

Prescriptions of obesity management drugs (OMDs) have increased, and these increasing trends are associated with online ...

Find out all you need to know about Ozempic and other weight loss drugs, including the dangers and side effects ...

Lexaria Bioscience Corp., a global innovator in drug delivery platforms, announced that it has received the necessary independent ethics board approval required for its contract research organization ...

Katharine Lang reports Glucagon-like peptide-1 (GLP-1) receptor agonist drugs such as liraglutide (Saxenda) and semaglutide (Ozempic, Wegovy) are being hailed as game changers in treating adult ...

Diabetes Care. 2015;38(6):1058-1066. The safety profile of liraglutide is under continuous surveillance through meticulous routine pharmacovigilance, with any cases of pancreatitis being analyzed ...

GLP-1s currently used for weight loss—although not all are expressly approved for this purpose—include Ozempic and Wegovy (semaglutide), Victoza and Saxenda (liraglutide), and Mounjaro and ...

The Study will compare an oral version of liraglutide, formulated from the DehydraTECH-processing of Saxenda® ("DehydraTECH-liraglutide") to the conventional injected liraglutide (Saxenda®).

The Study will compare an oral version of liraglutide, formulated from the DehydraTECH-processing of Saxenda to the conventional injected liraglutide. The Study is expected to be conducted with 8 ...